Model
Edge
Alnylam Pharmaceuticals, Inc.
0001782962
Filing Type
4
Filing Date
2/17/2025
Updated
2/18/25, 2:47 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership